BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26621850)

  • 1. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
    Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
    Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma.
    Zhu Y; Ye T; Yu X; Lei Q; Yang F; Xia Y; Song X; Liu L; Deng H; Gao T; Peng C; Zuo W; Xiong Y; Zhang L; Wang N; Zhao L; Xie Y; Yu L; Wei Y
    Sci Rep; 2016 Feb; 6():20253. PubMed ID: 26830149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
    Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
    J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition.
    Terrien X; Bonvin E; Corroyer S; Tabary O; Clement A; Henrion Caude A
    Biochem J; 2005 Dec; 392(Pt 3):457-65. PubMed ID: 16131350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma.
    Yang S; Li Z; Yi J; Pan M; Cao W; Ma J; Zhang P
    Anticancer Drugs; 2024 Jul; 35(6):512-524. PubMed ID: 38602174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?
    Haass NK
    Melanoma Manag; 2015 May; 2(2):93-95. PubMed ID: 30190835
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.
    Zhong X; Zhao E; Tang C; Zhang W; Tan J; Dong Z; Ding HF; Cui H
    Tumour Biol; 2016 Jun; 37(6):7615-23. PubMed ID: 26687647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Proteomics and Metabolomics Analysis of Insect Larva Brain: Novel Insights into the Molecular Mechanism of Insect Wandering Behavior.
    Li Y; Wang X; Hou Y; Zhou X; Chen Q; Guo C; Xia Q; Zhang Y; Zhao P
    J Proteome Res; 2016 Jan; 15(1):193-204. PubMed ID: 26644297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative transcriptomic analysis of silkworm Bmovo-1 and wild type silkworm ovary.
    Xue R; Hu X; Zhu L; Cao G; Huang M; Xue G; Song Z; Lu J; Chen X; Gong C
    Sci Rep; 2015 Dec; 5():17867. PubMed ID: 26643037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration.
    Liang G; Ding M; Lu H; Cao NA; Niu Y; Gao Y; Lu J
    Oncol Lett; 2015 Sep; 10(3):1527-1532. PubMed ID: 26622703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer.
    Hartmann S; Brands RC; Küchler N; Fuchs A; Linz C; Kübler AC; Müller-Richter UD
    Oncol Lett; 2015 Aug; 10(2):1211-1217. PubMed ID: 26622654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma.
    Yang J; Dong Z; Ren A; Fu G; Zhang K; Li C; Wang X; Cui H
    J Cell Mol Med; 2020 Apr; 24(7):4245-4260. PubMed ID: 32141702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells.
    Koch DT; Yu H; Beirith I; Schirren M; Drefs M; Liu Y; Knoblauch M; Koliogiannis D; Sheng W; De Toni EN; Bazhin AV; Renz BW; Guba MO; Werner J; Ilmer M
    J Transl Med; 2023 Dec; 21(1):876. PubMed ID: 38041179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition.
    Liu W; Ji Y; Wang F; Li C; Shi S; Liu R; Li Q; Guo L; Liu Y; Cui H
    BMC Cancer; 2023 Jun; 23(1):602. PubMed ID: 37386395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Assessment of Anti-Melanoma Potential of Tigecycline-Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells.
    Rok J; Kowalska J; Rzepka Z; Stencel D; Skorek A; Banach K; Wrześniok D
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed Drugs in Gastric Cancer.
    Araújo D; Ribeiro E; Amorim I; Vale N
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay.
    Elgazzar D; Aboubakr M; Bayoumi H; Ibrahim AN; Sorour SM; El-Hewaity M; Elsayed AM; Shehata SA; Bayoumi KA; Alsieni M; Behery M; Abdelrahaman D; Ibrahim SF; Abdeen A
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Pfab C; Schnobrich L; Eldnasoury S; Gessner A; El-Najjar N
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
    Islam S; Wang S; Bowden N; Martin J; Head R
    Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis.
    Li N; Zhao Z; Liu P; Zheng Y; Cai S; Sun Y; Wang B
    Mol Ther Oncolytics; 2021 Mar; 20():583-595. PubMed ID: 33768140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.